百勝中國-S(9987.HK)高開5.64% 將派發季度股息0.12美元/股
格隆匯2月10日丨百勝中國-S(9987.HK)高開5.64%報367港元,市值1542億港元。公司將於3月29日派發季度股息每股0.12美元。該股公佈業績後於昨日收跌近3%。財報顯示,百勝中國2021年全年實現總收入98.5億美元,同比增加19%;淨利潤9.9億美元,同比增加26%。看似業績增長的背後,百勝中國的經營情況不容樂觀。從餐廳利潤率看,百勝中國2021年全年的餐廳利潤率為13.7%,上年同期的餐廳利潤率為14.9%。2021年百勝中國同店銷售額較去年同期下降1%,2021年四季度同店銷售額同比下降11%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.